Ad hoc: Substantial sales and revenue growth in 2013

Villingen-Schwenningen, 25 March 2014: NEXUS AG, Villingen-Schwenningen, listed in Prime Standard increased its consolidated sales of KEUR 62,340 in the previous year to KEUR 73,263 (+17.5%) in 2013. The Group annual surplus increased by 26.1% to KEUR 7,220 (previous year: KEUR 5,728).

NEXUS AG was again able to achieve two-fi gure growth both in sales and revenue in 2013 and consequently continue its development of the previous years.

Sales in the core business, Health Care Software, increased by 14.1% to KEUR 64,940 (previous year: KEUR 56,921) over the whole year. The Healthcare Service Division had approx. 53.6% higher sales with KEUR 8,323 than in the previous year (KEUR 5,419). The foreign share of Group sales was 42.8% compared to 44.7% in the same period of the previous year.

The Group annual surplus was KEUR 7,220 following KEUR 5,728 in 2012 (+26.1%). The Group result before tax on income improved from KEUR 5,789 in 2012 to KEUR 7,078 (+22.3%). The EBITDA reached KEUR 13,998 following KEUR 11,820 in the previous year (+18.4%). The result per share increased by 19.1% to 50 cents (2012: 42 cents).

On 31 December 2013, the balance sheet showed stockholders equity amounting to approx. KEUR 72,369 (previous year: KEUR 68,113) as well as cash and securities in the amount of KEUR 23,804 (previous year: KEUR 23,051). There are no essential bank liabilities. The equity capital rate was 71.0%.

The Supervisory Board and the Executive Board will proposed at the annual general meeting to pay a dividend of 12 cents per share.


Auf der Steig 6
78052 Villingen-Schwenningen

Phone: +49 (0)7721 8482-0

Information material